Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cancer Discovery|June 4, 2015
Combined EGFR/MEK Inhibition Prevents the Emergence of Resistance in EGFR-Mutant Lung CancerErin M Tricker, Chunxiao Xu, Sharmeen Uddin, et al.
American Journal of Hematology|April 22, 2006
Clustered incidence of acute promyelocytic leukemia during gefitinib treatment for non-small-cell lung cancer: experience at a single institutionKeitaro Matsuo, Katsuyuki Kiura, Masahiro Tabata, et al.
Lung Cancer (Amsterdam, Netherlands)|July 20, 2011
The anti-proliferative effect of heat shock protein 90 inhibitor, 17-DMAG, on non-small-cell lung cancers being resistant to EGFR tyrosine kinase inhibitorNaruyuki Kobayashi, Shinichi Toyooka, Junichi Soh, et al.
Anticancer Research|August 6, 2005
Phase I study of irinotecan and amrubicin in patients with advanced non-small-cell lung cancerKatsuyuki Hotta, Nagio Takigawa, Katsuyuki Kiura, et al.
Cancer Research|April 2, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 InhibitorsTakayuki Kosaka, Junko Tanizaki, Raymond M Paranal, et al.
Molecular Oncology|March 20, 2020
Genomic and pathological heterogeneity in clinically diagnosed small cell lung cancer in never/light smokers identifies therapeutically targetable alterationsAtsuko Ogino, Jihyun Choi, Mika Lin, et al.
Molecular Cancer Therapeutics|February 4, 2021
ERK Inhibitor LY3214996-Based Treatment Strategies for RAS-Driven Lung CancerJens Köhler, Yutong Zhao, Jiaqi Li, et al.
Cancer Research|July 28, 2011
A novel ALK secondary mutation and EGFR signaling cause resistance to ALK kinase inhibitorsTakaaki Sasaki, Jussi Koivunen, Atsuko Ogino, et al.
Nature Communications|January 2, 2025
Intratumor heterogeneity of EGFR expression mediates targeted therapy resistance and formation of drug tolerant microenvironmentBassel Alsaed, Linh Lin, Jieun Son, et al.
Cancer Cell|September 23, 2022
MPS1 inhibition primes immunogenicity of KRAS-LKB1 mutant lung cancerShunsuke Kitajima, Tetsuo Tani, Benjamin F Springer, et al.
Pageof 3